MedTrace Logo

3-year Clinical Performance of Prefabricated and Composite Veneers

NCT05984472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-08-09

No results posted yet for this study

Summary

The aim of this study was to evaluate the clinical performances of Edelweiss prefabricated veneers and direct resin composite restorations (Ceram-X Duo SphereTec) performed with U- veneer transparent templates used for anterior diastema closure and tooth reshaping over 3-year.

The patient group consisted of individuals who applied for aesthetic complaints on their anterior teeth. 21 volunteer individuals without systemic disease were included in the study. Patients were randomly selected for each group. In Group 1; 38 teeth (10 patients) were restored with Edelweiss prefabricated veneers (Edelweiss Dentistry) in combination with Edelweiss nanohybrid resin composite (Edelweiss Dentistry) and Prime\&Bond Universal (Dentsply Sirona) adhesive system. In Group 2; 36 teeth (11 patients) were restored with Ceram-X Duo SphereTec (Dentsply Sirona) resin composite in combination with U- veneer (Ultradent) transparent templates and Prime\&Bond Universal adhesive systems. Properties of the restorations were evaluated at baseline, 6, 12, 24, and 36 months using Modified Ryge Criteria (USPHS Criteria). Data were evaluated using Chi-Square and Fisher's Exact tests (p=0.05).

Conditions

  • Dental Diseases
  • Tooth Discoloration

Interventions

PROCEDURE

Edelweiss prefabricated veneers

Individual Randomized Clinical Trial

PROCEDURE

Ceram-X Duo SphereTec with U-Veneer

Ceram-X Duo SphereTec with U-Veneer

Sponsors & Collaborators

  • Ege University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2019-12-30
Completion
2020-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05984472 on ClinicalTrials.gov